Bulk and single cell RNA sequencing analyses of GBM Primary and Recurrent, early and late passages, DMSO / TMZ treatment.
Single-cell RNA-seq · human · 37 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart.
- Organism
- Homo sapiens (human)
- Samples
- 37 samples: 36 distinct titles, 1 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrenceNeuron · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE278154_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1165770 and SRA study SRP535250. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 37 sample titles: 36 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8540894 180327-I-PO-I
- GSM8540895 180327-I-PO-I_2
- GSM8540896 180327-I-PO-I_freeze
- GSM8540897 3752_XX-1659_032522_180327-1-P10
- GSM8540898 3752_XX-1659_032522_180327-1-P10_HTO
- GSM8540899 2283_171003_MIX
- GSM8540900 2283_171003_MIX_HTO
- GSM8540901 2226_160811_2
- GSM8540902 2227_160811_5
- GSM8540903 4345_XX-2001_160811-1_P10_1-4
- GSM8540904 4345_XX-2001_160811-1_P10_1-4_HTO
- GSM8540905 2421_180327_T1_TMZ
- GSM8540906 2421_180327_T1_TMZ_HTO
- GSM8540907 2450_180327_DMSO
- GSM8540908 2450_180327_DMSO_HTO
- GSM8540909 O2b_IGO_07618_K_13_S1
- GSM8540910 O3a_IGO_07618_K_18_S2
- GSM8540911 O3b_IGO_07618_K_19_S16
- GSM8540912 O8b_IGO_07618_K_14_S5
- GSM8540913 O8c_IGO_07618_K_15_S14
- GSM8540914 O9a_IGO_07618_K_16_S15
- GSM8540915 V3a_IGO_07618_K_5_S9
- GSM8540916 V4a_IGO_07618_K_6_S10
- GSM8540917 V4b_IGO_07618_K_7_S19
- GSM8540918 V8a_IGO_07618_K_8_S11
- GSM8540919 V8b_IGO_07618_K_10_S3
- GSM8540920 B1b_IGO_07618_K_9_S12
- GSM8540921 B2a_IGO_07618_K_17_S6
- GSM8540922 B8a_IGO_07618_K_11_S13
- GSM8540923 B8b_IGO_07618_K_12_S4
- GSM8540924 rZ0b_IGO_07618_V_23_S19
- GSM8540925 rZ4a_IGO_07618_V_24_S20
- GSM8540926 rZ4b_IGO_07618_V_25_S21
- GSM8540927 rZ8a_IGO_07618_V_32_S24
- GSM8540928 rZ8b_IGO_07618_V_33_S25
- GSM8540929 rZ10a_IGO_07618_V_35_S26
- GSM8540930 rZ10b_IGO_07618_V_36_S27
- GSE270513 Monitor the dynamic changes of GBM cell lines under TTFields treatment 52 samples shares gbm, treatment
- GSE193525 TTFields plus TMZ treatment effects on newly diagnosed Glioblastoma patients in peripheral blood 24 samples shares tmz, treatment
- GSE229357 Effect of treatment with 5uM of the type I PRMT inhibitor MS023 dissolved in DMSO for 3 days and of a stably transduced PRMT1 specific dox-inducible knockdown over 4 days in ccRCC cell line models RCC243 and 786-0 20 samples shares dmso, treatment
- GSE324741 Detection of transcriptomic changes in N9 and N33 GBM cells following treatment with small molecular inhibitors of MK-0752, WP1066 and retinoic acid 18 samples shares gbm, treatment
- GSE255437 Analysis of A375 and SKMEL-103 cells after treatment with with DMSO as control or BAY-850 12 samples shares dmso, treatment
- GSE311738 E96A TMZ Treatment Study 12 samples shares tmz, treatment
- GSE296419 The critical role of the host endogenous immune compartment after intracerebroventricular CAR T cell therapy in recurrent GBM 143 samples shares gbm, recurrent
- GSE270047 Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinoma 434 samples shares recurrent, treatment
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.